Search
Search Results
##search.searchResults.foundPlural##
-
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1419PDF: 500HTML: 239 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2549PDF: 734HTML: 194 -
-
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2712PDF: 929HTML: 3100flowcytometric result of peripheral blood sample: 155 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2398PDF: 759HTML: 1720 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2692PDF: 1069HTML: 3252 -
Pseudo-differentiation syndrome
1281PDF: 632HTML: 10830Figure 1: peripheral blood showing myeloblasts with auer rods: 105Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 93Figure 3: CXR showing pulmonary infiltartes with consolidation: 115Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 92Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 108 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2731PDF: 819HTML: 6496Untitled: 204Untitled: 167Untitled: 164Untitled: 188 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2680PDF: 1752HTML: 3630Pellagatti Fig 1: 183Pellagatti Fig. 2: 183 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1687PDF: 929HTML: 126 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
898PDF: 485HTML: 170 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1814PDF: 872HTML: 1740Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 142 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1525PDF: 773HTML: 137 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1133PDF: 721HTML: 1330Figure 1: 154Figure 2: 152 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
664PDF: 784PDF Supp. Files: 68HTML: 170 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1130PDF: 683Html: 78 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1929PDF: 733HTML: 3098 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3459PDF: 1442HTML: 4281CoverLetter: 167Figure1: 175 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1772PDF: 875HTML: 930Referring article: 715 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
899PDF: 1180HTML: 88 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13178PDF: 929HTML: 7274







